Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5041 AL 5055

Human stem cell models of dementia

Livesey FJ.

Hum Mol Genet. 2014 Sep 15;23(R1):R35-9. doi: 10.1093/hmg/ddu302. Epub 2014 Jun 16.

An ambient assisted living approach in designing domiciliary services combined with innovative technologies for patients with Alzheimer's disease: a case study

Cavallo F, Aquilano M, Arvati M.

Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):69-77. doi: 10.1177/1533317514539724. Epub 2014 Jun 20.

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial

Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N.

Clin Interv Aging. 2014 Jun 18;9:947-61. doi: 10.2147/CIA.S65625. eCollection 2014.

Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease

Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner J, Dea D.

Neurobiol Aging. 2014 Sep;35 Suppl 2(Suppl 2):S3-10. doi: 10.1016/j.neurobiolaging.2014.03.037. Epub 2014 May 15.

Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease

Wang P, Ding K.

Protein Pept Lett. 2014;21(10):1048-56. doi: 10.2174/0929866521666140626095145.

Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?

Panza F, Solfrizzi V, Imbimbo BP, Logroscino G.

Expert Opin Biol Ther. 2014 Oct;14(10):1465-76. doi: 10.1517/14712598.2014.935332. Epub 2014 Jun 30.

Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC.

Curr Med Res Opin. 2014 Oct;30(10):2021-32. doi: 10.1185/03007995.2014.939167. Epub 2014 Jul 14.

Epigenetic drug discovery for Alzheimer's disease

Cacabelos R, Torrellas C.

Expert Opin Drug Discov. 2014 Sep;9(9):1059-86. doi: 10.1517/17460441.2014.930124. Epub 2014 Jul 3.

Targeting TNF: a therapeutic strategy for Alzheimer's disease

Cheng X, Shen Y, Li R.

Drug Discov Today. 2014 Nov;19(11):1822-1827. doi: 10.1016/j.drudis.2014.06.029. Epub 2014 Jul 4.

Statins for the treatment of dementia

McGuinness B, Craig D, Bullock R, Malouf R, Passmore P.

Cochrane Database Syst Rev. 2014 Jul 8;2014(7):CD007514. doi: 10.1002/14651858.CD007514.pub3.

ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease

Romero A, Egea J, González-Muñoz GC, Martín de Saavedra MD, del Barrio L, Rodríguez-Franco MI, Conde S, López MG, Villarroya M, de los Ríos C.

ACS Chem Neurosci. 2014 Sep 17;5(9):770-5. doi: 10.1021/cn500131t. Epub 2014 Jul 15.

Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study

Boada M, Ramos-Fernández E, Guivernau B, Muñoz FJ, Costa M, Ortiz AM, Jorquera JI, Núñez L, Torres M, Páez A.

Neurologia. 2016 Sep;31(7):473-81. doi: 10.1016/j.nrl.2014.02.003. Epub 2014 Jul 9.

A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia

Haig GM, Pritchett Y, Meier A, Othman AA, Hall C, Gault LM, Lenz RA.

J Alzheimers Dis. 2014;42(3):959-71. doi: 10.3233/JAD-140291.

Diverse molecular targets for therapeutic strategies in Alzheimer's disease

Han SH, Mook-Jung I.

J Korean Med Sci. 2014 Jul;29(7):893-902. doi: 10.3346/jkms.2014.29.7.893. Epub 2014 Jul 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias